There’s no direct link between vision loss and taking the weight loss and diabetes drugs such as Ozempic, Wegovy, Mounjaro, ...

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Beyond treating diabetes and helping people lose weight, GLP-1s may also improve libido. But the reasons are as complex as ...

From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...

GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.

More Canadian employers are offering benefits that are not traditionally offered in most benefits programs, according to a recent report. Currently, 70 per cent of employers are offering fertility ...

A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...

Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...

GLP-1-directed drugs have already shown promise in clinical trials involving people with sleep apnoea – Lilly's Zepbound (tirzepatide) was approved for that indication in the US last year ...